These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6836729)

  • 1. Pharmaceuticals in the Third World.
    Peretz SM
    Trop Doct; 1983 Jan; 13(1):3-5. PubMed ID: 6836729
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing in the Third World. Food, not pharmaceuticals.
    Melrose D
    Nurs Times; 1985 Sep 18-24; 81(38):27-9. PubMed ID: 3850544
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug companies and third world: a case study in neglect. Medicine merchants: a special report.
    McNeil DG
    N Y Times Web; 2000 May; ():A1,6. PubMed ID: 11873794
    [No Abstract]   [Full Text] [Related]  

  • 4. Globalization of the pharmaceutical industry and the growing dependency of developing countries: the case of Turkey.
    Semin S; Güldal D
    Int J Health Serv; 2008; 38(2):379-98. PubMed ID: 18459286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparks fly over patents and vital drugs at world health assembly.
    Kapp C
    Lancet; 2003 May; 361(9372):1873. PubMed ID: 12788578
    [No Abstract]   [Full Text] [Related]  

  • 6. Legal aspects of on-line pharmacy: free movement of goods is not tantamount to free provision of services!
    Michel L
    Acta Chir Belg; 2004 Aug; 104(4):371-2. PubMed ID: 15469144
    [No Abstract]   [Full Text] [Related]  

  • 7. Trade, TRIPS, and pharmaceuticals.
    Smith RD; Correa C; Oh C
    Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO: the casualties and compromises of renewal.
    Bale H
    Lancet; 2002 Sep; 360(9337):953-4. PubMed ID: 12354505
    [No Abstract]   [Full Text] [Related]  

  • 10. Redistribution of risk throughout the pharmaceutical industry.
    Scheur BS
    Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The drug industry is a barrier to diabetes care in poor countries.
    Yudkin JS
    BMJ; 2012 May; 344():e3018. PubMed ID: 22636786
    [No Abstract]   [Full Text] [Related]  

  • 12. Combating counterfeit drugs.
    Land T
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731208
    [No Abstract]   [Full Text] [Related]  

  • 13. Are rich nations up for drug reform?
    Check E
    Nature; 2006 May; 441(7090):135. PubMed ID: 16688137
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing the marketing message.
    Navarro RP
    Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug companies should cut prices for developing countries, says G8 report.
    Walgate R
    Bull World Health Organ; 2003; 81(1):72-3. PubMed ID: 12640481
    [No Abstract]   [Full Text] [Related]  

  • 16. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical manufacturer prescription assistance programs: are they worth it?
    Chen JT; Summers KH
    J Manag Care Pharm; 2007 Sep; 13(7):611-3. PubMed ID: 17874869
    [No Abstract]   [Full Text] [Related]  

  • 18. Let the gamification begin.
    Drell L
    Mark Health Serv; 2014; 34(1):24-7. PubMed ID: 24741765
    [No Abstract]   [Full Text] [Related]  

  • 19. Strange symbiosis.
    Navarro RP
    Med Interface; 1996 Oct; 9(10):78-9, 82. PubMed ID: 10161514
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacies take uniform price demands to court.
    Moskowitz DB
    J Am Health Policy; 1994; 4(4):24-7. PubMed ID: 10136676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.